#77 - Central Nervous System Drug Development with Industry Expert Dr. Errol De Souza (Chairman @Bionomics)
Listen now
Description
In this episode we learn how drugs are developed for treating mental health differences (Central Nervous System) and specifically how a cutting edge PTSD drug is being developed today by Bionomics.
Our guest is Dr. Errol De Souza, PhD, Executive Chairman of the Board of Directors at Bionomics. Bionomics just raised nearly $16mm to conduct clinical trials on their revolutionary drug to treat PTSD.
More Episodes
What is the future of legal cannabis from a retail / e-commerce perspective? Today's guest, Socrates Rosenfeld, Co-Founder and CEO of Jane Technologies explains. Jane is an e-commerce solution for the Cannabis space that supports nearly 3,000 dispensaries and handles more than 20% of the legal...
Published 12/13/21
Published 12/13/21
Alyson Watson is CEO and co-founder of Modern Health, a mental health unicorn! Modern Health is a global mental health benefits solution for employers that covers the spectrum of mental wellbeing needs from tech enabled solutions to professional support solutions on one platform.
Published 11/02/21
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
